Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL femoral nerve block for postsurgical analgesia after total knee arthroplasty
2015-005179-25Phase 3Completed
- Sponsor
- Pacira BioSciences
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Pacira BioSciences. Primary endpoint: Area under the curve of VAS pain intensity scores through 72 hours. Started Mar 2016; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2015-005179-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005179-25.